A Phase I, Open-Label, Positron Emission Tomography (PET) Study Healthy Subjects Following a Single Oral Dose of OPC-34712.
Phase of Trial: Phase I
Latest Information Update: 08 May 2010
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 08 May 2010 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 08 May 2010 Actual patient number (15) added as reported by ClinicalTrials.gov.
- 08 May 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.